Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$52.16 - $64.19 $417 - $513
-8 Reduced 0.02%
37,259 $2.34 Million
Q3 2023

Nov 09, 2023

SELL
$57.77 - $65.93 $148,411 - $169,374
-2,569 Reduced 6.45%
37,267 $2.15 Million
Q2 2023

Aug 14, 2023

BUY
$60.95 - $75.51 $50,466 - $62,522
828 Added 2.12%
39,836 $2.48 Million
Q1 2023

May 12, 2023

SELL
$70.23 - $86.01 $116,932 - $143,206
-1,665 Reduced 4.09%
39,008 $2.82 Million
Q4 2022

Feb 08, 2023

BUY
$67.18 - $84.11 $417,322 - $522,491
6,212 Added 18.03%
40,673 $3.27 Million
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $37,126 - $46,484
561 Added 1.65%
34,461 $2.3 Million
Q2 2022

Aug 12, 2022

BUY
$66.18 - $83.18 $27,729 - $34,852
419 Added 1.25%
33,900 $2.58 Million
Q1 2022

May 13, 2022

BUY
$66.02 - $79.71 $503,468 - $607,868
7,626 Added 29.5%
33,481 $2.66 Million
Q4 2021

Feb 11, 2022

SELL
$63.34 - $74.11 $45,351 - $53,062
-716 Reduced 2.69%
25,855 $1.9 Million
Q3 2021

Nov 10, 2021

BUY
$68.67 - $84.02 $823,559 - $1.01 Million
11,993 Added 82.27%
26,571 $1.83 Million
Q2 2021

Aug 13, 2021

BUY
$79.87 - $87.53 $1.16 Million - $1.28 Million
14,578 New
14,578 $1.23 Million
Q4 2020

Feb 08, 2021

SELL
$80.74 - $97.7 $930,689 - $1.13 Million
-11,527 Closed
0 $0
Q3 2020

Oct 30, 2020

SELL
$85.07 - $109.69 $75,542 - $97,404
-888 Reduced 7.15%
11,527 $1.03 Million
Q2 2020

Jul 31, 2020

BUY
$74.18 - $108.93 $920,944 - $1.35 Million
12,415 New
12,415 $1.29 Million
Q4 2019

Feb 13, 2020

SELL
$73.04 - $95.72 $10.3 Million - $13.5 Million
-141,519 Closed
0 $0
Q3 2019

Nov 13, 2019

SELL
$72.82 - $86.52 $1.83 Million - $2.18 Million
-25,195 Reduced 15.11%
141,519 $10.5 Million
Q1 2019

May 13, 2019

SELL
$63.56 - $88.17 $6.98 Million - $9.68 Million
-109,803 Reduced 39.71%
166,714 $14.3 Million
Q4 2018

Feb 13, 2019

BUY
$58.5 - $69.94 $16.2 Million - $19.3 Million
276,517 New
276,517 $17.6 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Prudential PLC Portfolio

Follow Prudential PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.